Testing effectiveness (Phase 2)Study completedNCT01076543
What this trial is testing
Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
Who this might be right for
AIDS-Related Hodgkin LymphomaRecurrent Adult Hodgkin LymphomaRecurrent Follicular Lymphoma+5 more
National Cancer Institute (NCI) 110